Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
26 Jun, 2026, 12.19 PM IST
Union minister Shivraj Singh Chouhan shares agricultural experience, urges farmers to adopt traditional farming methodsSharing his experience in a post on X, Chouhan noted that before the main paddy transplantation, dhaincha (Sesbania aculeata) was grown in ...
26 Jun, 2026, 11.18 AM IST
Delhi CM Rekha Gupta directs district administration to inspect Shalimar Bagh's Fortis HospitalFortis Hospital inspection: Delhi Chief Minister Rekha Gupta has ordered an immediate inspection of Shalimar Bagh's Fortis Hospital followi...
26 Jun, 2026, 09.08 AM IST
Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
26 Jun, 2026, 08.10 AM IST
Tamil Nadu CM strongly opposes Centre's NLC disinvestment planTamil Nadu Chief Minister C. Joseph Vijay has strongly opposed the Union Government's plan to disinvest up to three percent of its equity i...
25 Jun, 2026, 05.53 PM IST
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
25 Jun, 2026, 02.09 PM IST
Areion Assets Management launches $60 million AIF to tap India's special situations marketAreion Assets Management has launched a $60 million Category III AIF from GIFT City targeting India’s special situations market. The fund w...
25 Jun, 2026, 11.00 AM IST
RBI says no to special exposure relaxations for state NBFCsThe Reserve Bank of India has firmly rejected requests for special exemptions from concentration norms for government-owned NBFCs, emphasiz...
25 Jun, 2026, 01.23 AM IST
Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
24 Jun, 2026, 01.16 PM IST
Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata MotorsIndian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...
24 Jun, 2026, 06.01 AM IST
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
24 Jun, 2026, 01.16 AM IST
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
23 Jun, 2026, 08.03 PM IST
Income Tax AY 2026-27: Even if your salary income is below Rs 12.75 lakh, you still need to pay tax for these incomesIncome Tax AY 2026-27: Salaried individuals earning up to Rs 12.75 lakh annually may enjoy zero tax liability due to enhanced Section 87A r...
23 Jun, 2026, 02.14 PM IST
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
23 Jun, 2026, 12.05 PM IST
K2 Infra bags Rs 390.91 crore Telangana road projectK2 Infra Limited has bagged a significant Rs 390.91 crore road project from the Telangana government. This initiative focuses on enhancing ...
22 Jun, 2026, 01.55 PM IST
Aprilia Tuono 457 Special Edition launched in India: Price, features and key changes explainedAprilia has unveiled its Tuono 457 Special Edition in India, priced at Rs 3.99 lakh. This new variant boasts cosmetic tweaks, improved ride...
22 Jun, 2026, 12.00 PM IST
US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...
18 Jun, 2026, 10.53 PM IST